Abstract-An accumulating body of evidence suggests that offspring of mothers with preeclampsia have higher blood pressure during childhood and young adulthood compared with women without preeclampsia. However, the evidence with regard to offspring glucose metabolism and lipids is more scant. We examined whether maternal hypertensive disorders of pregnancy (preeclampsia and gestational hypertension) are associated with a range of cardiometabolic health measures in adolescent offspring. We included data for mother-offspring pairs from a United Kingdom prospective birth cohort (the Avon Longitudinal Study of Parents and Children). Repeat antenatal clinic measures of blood pressure and proteinuria (median 14 and 11, respectively) were used to ascertain maternal preeclampsia (n=53) and gestational hypertension (n=431). Offspring had blood pressure (n=4438), and fasting lipids, insulin, and glucose (n=2888) measured at a mean age of 17 years. There was no strong evidence of differences in fasting insulin, glucose, or lipid concentrations. Systolic and diastolic blood pressures were higher in offspring of mothers with gestational hypertension (mean difference, 2.06 mm Hg; 95% confidence interval, 1.28-2.84 and 1.11 mm Hg; 95% confidence interval, 0.54-1.69, respectively) and preeclampsia (1.12 mm Hg; 95% confidence interval, −0.89-3.12 and 1.71 mm Hg; 95% confidence interval, 0.23-3.17, respectively) compared with offspring of mothers without hypertensive disorders of pregnancy, adjusting for potential confounders (age, sex, maternal age at delivery, household social class, prepregnancy body mass index, parity, and smoking in pregnancy). Results suggest a specific association between maternal hypertensive disorders of pregnancy and offspring blood pressure that may be driven by genetics or familial nongenetic risk factors particular to blood pressure. 
W omen who develop preeclampsia in pregnancy are at increased risk of cardiovascular disease (CVD) later in life. 1, 2 More recent evidence suggests that preeclampsia may also have implication for offspring cardiovascular health, 3 with 1 study reporting an almost doubling of the risk of stroke in adulthood in offspring of women with preeclampsia. 4 A systematic review of studies examining associations of preeclampsia with offspring classic CVD risk factors found that offspring exposed to maternal preeclampsia had higher mean systolic blood pressure (SBP; 2.39 mm Hg; 95% confidence interval, 1.74-3.05), and diastolic blood pressure (DBP; 1.35 mm Hg; 95% confidence interval, 0.90-1.80) during childhood and young adulthood compared with those not exposed to preeclampsia in utero. 5 Authors also reported finding limited evidence with regard to offspring lipids (4 studies) and glucose metabolism (2 small studies) later in life and concluded that the evidence was insufficient to allow definitive conclusions.
Three main mechanisms could explain associations of maternal preeclampsia with offspring blood pressure and potentially other measures of cardiometabolic health. First, a shared familial nongenetic risk factor may account for both preeclampsia and adverse cardiometabolic health. Our previous work looking at blood pressure alone suggests that familial body mass index (BMI), a likely candidate, does not explain this association. 6 Shared genetic variants accounting for both preeclampsia and adverse cardiovascular health could be a second potential mechanism. A direct intrauterine effect is also possible. According to this mechanism, exposure to a preeclamptic environment in utero has a lasting effect on offspring cardiometabolic health such as via effects on cardiac and vascular structure and function, as well as on renal function, inflammation, and autoimmune responses. 7, 8 Using data from the Avon Longitudinal Study of Parents and Children (ALSPAC), we previously reported associations between maternal gestational hypertension and preeclampsia (jointly known as hypertensive disorders of pregnancy [HDP] ) and greater offspring blood pressure at both mean age of 9.9 and 10.7 years, 6, 9 but no associations with endothelial function or arterial stiffness at a mean age of 10.7 years, or with markers of chronic inflammation, lipids, or apolipoproteins at a mean age of 9.9 years. 9 We interpreted the specificity of the association between maternal HDP and offspring blood pressure as more compatible with shared genetics than with long term programming by exposure to HDP in utero. 9 If the latter pathway was operational, we would arguably expect to find associations with other measures of offspring cardiometabolic health in addition to blood pressure.
The main aim of the present study is to examine associations of maternal HDP with fasting insulin and glucose measured post puberty at a mean age of 17 years. For completion we also report on associations with lipids and blood pressure measures at 17 years, although association with these measures at 9.9 and 10.7 years has been previously reported.
Methods

Study Population
The ALSPAC is a prospective population-based pregnancy cohort (www.alspac.bris.ac.uk). 10, 11 Briefly, pregnant women resident in the Bristol area with an expected date of delivery between April 1, 1991 and December 31, 1992 were eligible for inclusion and 14 541 pregnancies were enrolled. A total of 13 617 women with a live singleton birth consented to have their obstetric data abstracted from medical records. From the age of 7 years, offspring were invited to regular clinic assessments. Mothers for whom obstetric data were available and whose offspring attended the 15+ or 17+ year clinic assessments were eligible for inclusion in this study, with preference given to measures obtained at the 17+ year assessment (Figure) .
Ethical approval for this study was obtained from the ALSPAC Law and Ethics Committee and the Local Research Ethics Committee. All participants gave written informed consent.
Hypertensive Disorders of Pregnancy
Obstetric data abstractions included every measurement of SBP and DBP and proteinuria entered into the medical records and the corresponding gestational age and date at the time of these measurements. These measurements were obtained in routine clinical practice by trained midwives and obstetricians. The median number (interquartile range) of blood pressure measurements in pregnancy was 14 (11) (12) (13) (14) (15) (16) and that of urine measurements was 11 (10) (11) (12) (13) (14) . We applied the International Society for the Study of Hypertension in Pregnancy 12 criteria to all of the clinic data to determine women with preeclampsia and those with gestational hypertension. Using these criteria, preeclampsia was defined as a SBP ≥140 mm Hg or a DBP ≥90 mm Hg, measured on ≥2 occasions after 20 weeks of gestation, with proteinuria, diagnosed if the protein reading on dipstick testing (Albustix; Ames Company, Elkhart, Indiana) was ≥1 (30 mg/dL), occurring at the same time as the elevated blood pressure. Gestational hypertension was defined as the same pattern of elevated blood pressure but without proteinuria. 12 Thus, all women were categorized into 1 of 3 mutually exclusive categories of no HDP, gestational hypertension, or preeclampsia. A total of 105 women without HDP reported to have hypertension before pregnancy and none with HDP. When these women were excluded from the analysis, results were unchanged to those presented here.
Outcomes
All outcomes were measured using the same procedures at the 15+ and 17+ year assessments.
Serum insulin was measured with an ELISA (Mercodia, Uppsala, Sweden) that does not cross-react with proinsulin. Plasma glucose was measured with an automated assay. Plasma triglyceride, total cholesterol, and high-density lipoprotein-cholesterol (HDL-C) concentrations were measured by modification of the standard Lipid Research Clinics Protocol using enzymatic reagents for lipid determination, and low-density lipoprotein-cholesterol concentration was determined from these, using the Friedwald equation. 13 Inter-and intra-assay coefficients of variation for lipids and glucose were all <5%. For insulin, interassay coefficient of variation was <9.3% and intra-assay coefficients of variation was <6.0%. SBP and DBP were measured on each arm using a Dinamap 9301 Vital Signs Monitor (Morton Medical, London, United Kingdom) with the participant resting, and their arm supported at chest level. At the age of 15 years, 2 readings were taken and at the age of 17 years 4 readings (2 on each arm). The mean values of these were used in analyses.
Assessment of Covariables
The following were considered as potential confounders: maternal age at delivery, maternal smoking in pregnancy, parity, household socioeconomic position, maternal prepregnancy BMI, and offspring sex and age at clinic visit. Gestational age, birthweight, mode of delivery (vaginal/Cesarean section), and offspring BMI at outcome assessment were considered potential mediators. Mode of delivery, gestational age, birth weight, and child's sex were extracted from medical records. Parity, parental occupation, maternal prepregnancy weight and height were obtained from questionnaires completed by the mothers at recruitment in early pregnancy. The highest parental occupation was used to allocate the children to family social class groups (classes I [professional/management] to V [unskilled manual workers], using the 1991 British Office of Population and Census Statistics classification). Information on smoking during pregnancy was obtained from questionnaires completed by mothers throughout pregnancy and was categorized as never smoked during pregnancy or smoked during first trimester only/throughout pregnancy. Maternal reported height and prepregnancy weight were used to calculate by guest on June 9, 2017 http://hyper.ahajournals.org/ Downloaded from maternal prepregnancy BMI; reported prepregnancy weight correlated highly (Pearson correlation coefficient=0.95) with measured weight at the first antenatal clinic. Offspring age, in months, was recorded at the clinic assessment visit. Weight and height were measured using standard procedures as previously described. Sodium intake was ascertained from three 1-day unweighed dietary diaries in which participants and carers recorded everything the participant ate and drank in household measures for 2 weekdays and 1 weekend day at the age of 13.5 years (dietary data were not collected at 15 or 17 years). Data from these diaries were used to determine offspring dietary sodium (salt) intake. Completed diaries were brought to the clinic and nutrition fieldworkers checked through the diaries to increase completeness and remove uncertainties. Diet diaries were transformed into food codes with associated weights in grams for each item of food and drink recorded, by the same fieldworker using the Diet in, Diet out program. Food codes and nutrient content, including sodium content, were derived from McCance and Widdowsons food tables and supplements, as previously described.
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Statistical Analysis
Characteristics of eligible included and excluded mother-offspring pairs were compared using χ 2 and t tests, as appropriate and characteristics of mother-offspring pairs that experienced gestational hypertension and preeclampsia were compared with characteristics of women without HDP using linear and logistic regression, as appropriate. Multivariable linear regression was used to assess the associations of HDP with offspring outcomes. In the basic model we adjusted for age and sex of offspring. In the second model we also adjusted for potential confounding by household social class, maternal age at delivery, parity, maternal smoking in pregnancy, and maternal prepregnancy BMI. The third model also examined potential mediation by mode of delivery (Cesarean section or not), gestational age, and birth weight and in the fourth model we added offspring BMI as a potential mediator instead of birth weight. We also examined whether controlling for sodium intake mediated associations between blood pressure and HDP. Values of triglycerides and insulin were log transformed. Results for these outcomes are presented as the percentage difference in insulin/triglycerides in offspring of mothers with gestational hypertension or preeclampsia compared with offspring of women without HDP.
Results
The Figure shows the study participant flow. Of 5975 eligible participants who attended the 17+ or the 15+ year assessment and for whom maternal obstetric data were available, complete data on all of exposure, potential confounders, mediators, and outcomes were available for 4438 mother-offspring pairs for blood pressure and 2888 for blood-based measures. Table 1 compares the characteristics of eligible participants who were included in analyses to those excluded because of missing outcome or covariable data. Compared with mothers included in analyses, excluded mothers were, on average, older at delivery, more likely to be from a manual social class, and to have smoked during pregnancy. Compared with included offspring, excluded offspring were more likely to be female and to have been a small for gestational baby. Excluded offspring also had a lower average birthweight, were younger at outcome assessment and had a lower BMI and higher insulin, glucose, and DBP. Differences were generally small in magnitude. Table 2 shows study sample characteristics by categories of maternal HDP: no HDP, gestational hypertension, and preeclampsia. Mothers who had gestational hypertension and those who had preeclampsia were less likely to smoke in pregnancy, had a greater prepregnancy BMI, were more likely to have a Cesarean section, and to deliver a baby small for gestational age. Mothers with preeclampsia were more likely to belong to a manual social class, had a shorter gestation, were more likely to deliver preterm, and had babies with a lower birthweight compared with mothers without HDP. Offspring of mothers who had a HDP had greater mean BMI, SBP, and DBP in adolescence compared with offspring of mothers without HDP. No differences in other characteristics, including offspring lipids, insulin, and glucose were noted. Table 3 shows the multivariable associations of HDP with offspring outcomes in adolescence. Mean insulin was higher in offspring of mothers with HDP when adjusting for offspring age and sex (model 1), but confidence intervals were wide and included the null value. Associations were attenuated toward the null on adjustment for confounders (model 2) and further attenuated when potential mediation by birth weight and adolescent BMI was accounted for (model 3). There was no strong evidence of associations of HDP with fasting glucose or lipids in any of the models. Offspring of mothers with gestational hypertension had higher mean SBP and DBP compared with offspring of mothers without HDP even when adjusting for potential confounders (models 1 and 2) and mediators (models 3 and 4). Mean DBP was highest in offspring of mothers with preeclampsia in all models, although confidence intervals were wider than those for gestational hypertension, and included the null in models 3 and 4. This is most likely because of the small number of women with preeclampsia. SBP was higher in offspring of mothers with preeclampsia compared with offspring of mothers without HDP in confounder-adjusted models (models 1 and 2), but the confidence intervals included the null value. When potential mediation by birth weight, BMI, and sodium intake was accounted for, the association was attenuated to the null. When analyses were repeated using data from the 17-year clinic alone, results were unchanged from those presented (results not given but available on request). Replacing birth weight with birth weight Z scores, that is, birth weight standardized for gestational age, did not change results.
Discussion
In this study, we found no strong evidence of associations between either preeclampsia or gestational hypertension and offspring fasting insulin, glucose, and lipids measured in adolescence, whereas mean SBP and DBP were higher in offspring of mothers who had HDP compared with mothers who did not have HDP.
The higher mean SBP and DBP in offspring of mothers with HDP in our study are in line with a recent systematic review and meta-analysis that found both SBP and DBP to be elevated in offspring of women with preeclampsia. 5 Davis et al 5 also identified 2 studies that examined glucose metabolism. In a case-control study of 60 cases and 60 controls, there were no differences in insulin, glucose, or glucose:insulin ratio at the age of 12 years between offspring of women who had preeclampsia and offspring of women with normotensive pregnancies. 15 In another small study, preterm offspring of both preeclamptic mothers (n=19) and normotensive mothers had increased fasting glucose at 20 years of age compared with term offspring of mothers without preeclampsia (n=38; 5.04 and 5.08 versus 4.57 mmol/L). 16 More recently, Miettola et al 17 reported finding similar fasting insulin and glucose levels in offspring of preeclamptic mothers, mothers with gestational hypertension, and normotensive mothers at 16 years. This study, therefore, adds to the very limited evidence on associations of maternal HDP with offspring glucose metabolism.
The aforementioned studies also reported on lipids. Tenhola et al 15 found no differences in total cholesterol, HDL-C, lowdensity lipoprotein-cholesterol, and triglycerides between offspring of mothers with preeclampsia and control, whereas Lazdam et al 16 found higher low-density lipoprotein-cholesterol and total cholesterol but no differences in HDL-C and triglycerides between preterm offspring of mothers with preeclampsia and those whose mother did not have preeclampsia. A third study found higher total cholesterol in 5-to 8-yearold offspring of women with preeclampsia (n=26) compared with offspring of women without preeclampsia (n=17) but no differences in low-density lipoprotein-cholesterol, HDL-C, or triglycerides. 18 That study also reported no differences in angiogenic or inflammatory biomarkers between the 2 groups. 18 In the Northern Finland Birth Cohort there was no difference in lipid concentrations in offspring of preeclamptic mothers compared with normotensive mothers; offspring of mothers with gestational hypertension had higher total cholesterol and HDL-C but lower triglycerides compared with offspring of normotensive mothers. 17 Finally, we found no differences in lipids or inflammation biomarkers in the ALSPAC offspring at 9 to 12 years of age, 9 and no difference in endothelial function, arterial stiffness, brachial distensibility, and brachial artery diameter at a mean age of 10.7 years. Similarly, Kvehaugen et al 18 found no difference in endothelial function between offspring of preeclamptic and nonpreeclamptic mothers 5 to 8 years post delivery.
Several mechanisms could explain the isolated association between maternal HDP and offspring blood pressure. Exposure to HDP in utero could set offspring on a trajectory of higher blood pressure throughout life without affecting the Model 1: Adjusting for age and sex; model 2: adjusting for age, sex, household social class, maternal age at delivery, parity, maternal smoking in pregnancy, and maternal prepregnancy BMI; model 3: adjusting for age, sex, household social class, maternal age at delivery, parity, maternal smoking in pregnancy, maternal prepregnancy BMI, Cesarean section yes/no, gestational age, offspring birth weight, and BMI at outcome assessment; model 4: adjusting for age, sex, household social class, maternal age at delivery, parity, maternal smoking in pregnancy, maternal prepregnancy BMI, Cesarean section yes/no, gestational age, offspring BMI at outcome assessment, and sodium intake. CI indicates confidence interval; DBP, diastolic blood pressure; HDL, high-density lipoprotein; HDP, hypertensive disorders of pregnancy; LDL, low-density lipoprotein; and SBP, systolic blood pressure.
*Coefficients are the mean percent increase in the outcome compared with the reference category.
by guest on June 9, 2017 http://hyper.ahajournals.org/ Downloaded from other cardiometabolic health measures assessed here. Results of a small but elegant study comparing vascular dysfunction in siblings discordant in their exposure to maternal preeclampsia in utero found greater dysfunction (measured by right ventricular to right atrial pressure gradient and flow-mediated dilation) in the sibling exposed to preeclampsia (n=22) compared with the sibling not exposed to preeclampsia (n=10). 8 This is in line with a direct intrauterine effect on these measures, although genetic variation in the offspring may also contribute to the risk of preeclampsia 19 and is not controlled for in a sibling study.
Alternatively, it is possible that inherited genetic variants account for both maternal HDP and higher offspring blood pressure. Whether genetic variants associated with blood pressure in genome-wide association studies are associated with HDP is yet to be established. However, support for this interpretation comes from findings that the association of maternal blood pressure with offspring blood pressure is of very similar magnitude to that of paternal blood pressure with offspring blood pressure. 20 Essential hypertension in both parents has also been shown to be associated with offspring forearm endothelial dysfunction, with similar magnitudes of association for each parent, 21 suggesting again that an intrauterine mechanism is an unlikely explanation.
A third potential mechanism is a shared environmental exposure that is associated with HDP and blood pressure but not with other measures of cardiometabolic health. One such possibility is sodium (salt) intake, although controlling for sodium intake in offspring alone did not abolish associations of HDP with offspring cardiovascular biomarkers and vascular function measured at a mean age of 10.7 years, 9 or here at a mean age of 17 years.
Although our study is large, the number of women with HDP, and preeclampsia in particular, is limited. For this reason, we could not study early and late onset preeclampsia separately. It is possible that offspring of mothers with the more severe form of preeclampsia (early onset) may have a more adverse cardiometabolic profile than those with late onset preeclampsia. 22 Another limitation of our study is the loss to follow-up. However, results would be biased only if associations were substantially different among excluded participants and while this cannot be directly tested we cannot think of any reason that this would be the case and differences between eligible participants included and excluded from the study were generally small. Strengths of the study include the duration of follow-up, and the availability of data on a range of cardiometabolic outcomes and potential confounders and mediators. In addition, the availability of repeat measures of maternal blood pressure and proteinuria in pregnancy allowed us to apply a standard international definition of HDP to all women and not rely on clinical diagnoses for these outcomes.
To conclude, there was no strong evidence of differences in fasting insulin, glucose, and lipid concentrations between adolescent offspring of mothers with HDP and without HDP, whereas blood pressure was higher in offspring exposed to HDP in utero. On the basis of current evidence, we suggest that shared environmental exposure or genetic variation that accounts for both maternal HDP and higher offspring blood pressure is a likely explanation of our findings. Studies with sufficient power to detect associations between genetic variants associated with blood pressure outside of pregnancy and HDP would be valuable for testing the hypothesis that shared genetic variants are driving the specific association between maternal HDP and offspring blood pressure. Moreover, studies with better markers of metabolic health, cardiac structure and function, and atherosclerosis may provide additional insight and sibling studies would be useful for ascertaining whether observed associations are because of a direct intrauterine effect.
Perspectives
Women who develop preeclampsia in pregnancy are at increased risk of CVD later in life. Preeclampsia may also have implication for offspring cardiovascular health. A recent systematic review of studies examining associations of preeclampsia with offspring classic CVD risk factors found that offspring exposed to maternal preeclampsia had higher blood pressure during childhood and young adulthood compared with those not exposed to preeclampsia in utero. The evidence with regard to offspring glucose metabolism and lipids was deemed insufficient to allow definitive conclusions. The present study demonstrates associations between HDP and higher blood pressure, but no associations with fasting insulin, glucose, or lipids measured at the age of 16 years. We suggest that the isolated association of HDP with blood pressure may be because of shared genetic variation. Additional studies with better markers of metabolic health, cardiac structure and function, and atherosclerosis could be useful in clarifying the relationship of HDP with offspring cardiometabolic health. A better understanding of mechanisms can be gained from studies powered to detect associations of genetic variants with known associations with blood pressure and other cardiometabolic traits outside of pregnancy with HDP and from sibling studies comparing cardiometabolic outcomes in siblings discordant in their exposure to maternal HDP. Regardless of the underlying mechanism, the association between maternal HDP and offspring blood pressure should inform CVD prevention strategies.
